California Plasma Coalition (CalPlasma) is working to address barriers to source plasma donations and help save more lives.

Global biotechnology leader CSL has announced that the European Commission (EC) has approved ANDEMBRY (garadacimab), the ...

“We recognize that those with rare diseases often have complex needs that go unmet by traditional assistance,” said Green.

Astria advances innovative therapies for hereditary angioedema and atopic dermatitis. Strong cash position supports pivotal ...

Global biotechnology leader CSL (ASX:CSL; USOTC:CSLLY) today announced that the European Commission (EC) has approved ...

hereditary angioedema, chronic inflammatory demyelinating polyneuropathy, hemophilia and Von Willebrand disease, Kawasaki disease, and more. To care for children and adults living with these ...

HAE is a rare, chronic, debilitating, and potentially life-threatening genetic disorder characterized by recurrent and unpredictable attacks of angioedema. Attacks of HAE are often painful and can ...

While still robust, CSL half-year results last Weds revealed impact of an “alarming” fall off in 'flu vax rates, especially ...

Effective dyspnea evaluation in urgent care requires the usage of a systems-based framework for categorizing the differential ...

SELARSDI is approved for the treatment of moderate to severe plaque psoriasis and active psoriatic arthritis in adults and ...